Release date: April 5, 2010
Expiration date: April 5, 2011
Estimated time to complete activity: 1.75 hours

This activity has been designed to meet the educational needs
of physicians, physician assistants, nurse practitioners, registered
nurses, pharmacists, and respiratory therapists, involved in
the management of patients with chronic airway infections.
 

In this activity, participants will make choices at various decision
points in a series of case studies that affect the treatment of several
pulmonary diseases. These choices will serve as departure
points for review of the most recent understandings and data
on the subject of discussion, in an effort to improve the health
care provider’s evidence-based clinical decision-making skills,
and ultimately lead to improved patient care. This monograph
discusses three important respiratory diseases and will present
one case study for each section.
 

After completing this activity, the participant should be better
able to:
* Identify the scope of the problem that P aeruginosa infection
presents to patients with CF
* Compare existing and novel treatment modalities for treatment
of P aeruginosa in patients with CF
* Identify the underlying cause of non-CF bronchiectasis in
order to design an effective management strategy
* Identify the recommended therapies to be administered at
various stages of COPD progression
* Discuss the most recent data on the use of antibiotics for the
treatment of acute exacerbations of COPD
 

Program Chairman
Felix Ratjen, MD, PhD, FRCP(C)
Division Chief Respiratory Medicine
Professor of Pediatrics
Hospital for Sick Children
Toronto, Ontario, Canada

Keith C. Meyer, MD, MS, FACP, FCCP
Professor of Medicine
Medical Director of Lung Transplantation
Director, Adult Cystic Fibrosis Program
Director, Interstitial Lung Disease Clinic
Division of Allergy, Pulmonary, and Critical Care Medicine
University of Wisconsin School of Medicine and Public Health
Madison, WI

Christopher M. Oermann, MD
Associate Professor of Pediatrics
Center Director, Cystic Fibrosis Care Center
Associate Section Head for Administrative Affairs
Baylor College of Medicine
Medical Director of Respiratory Care
Texas Children’s Hospital
Houston, Texas

Gregory Tino, MD
Associate Professor of Medicine
Chief, Pulmonary Clinical Service
University of Pennsylvania Medical Center
Pulmonary, Allergy & Critical Care Division
Philadelphia, PA

Accreditation Statement
This activity has been planned and implemented in accordance
with the Essential Areas and policies of the Accreditation Council
for Continuing Medical Education (ACCME) through the joint
sponsorship of Postgraduate Institute for Medicine (PIM) and
HealthmattersCME. PIM is accredited by the ACCME to provide
continuing medical education for physicians.

Credit Designation
Postgraduate Institute for Medicine designates this educational
activity for a maximum of 1.75 AMA PRA Category 1 Credit(s)™.
Physicians should only claim credit commensurate with the
extent of their participation in the activity.
 

Accreditation Statement
Postgraduate Institute for Medicine is accredited
by the Accreditation Council for Pharmacy
Education as a provider of continuing pharmacy
education.

Credit Designation
Postgraduate Institute for Medicine designates this continuing
education activity for 1.7 contact hour(s) (0.17 CEUs) of the
Accreditation Council for Pharmacy Education.
(Universal Program Number - 809-999-10-10-087-H01-P)
 

Credit Designation
This educational activity for 1.7 contact hours is provided by Postgraduate Institute for Medicine.

Accreditation Statements
Postgraduate Institute for Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

California Board of Registered Nursing
Postgraduate Institute for Medicine is approved by the California Board of Registered Nursing, Provider Number 13485 for 2.1 contact hours.
 

This program has been approved for a maximum of 1.75 contact hours Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care, 9425 N.
MacArthur Blvd., Suite 100, Irving, TX 75063.
Course # 202759000
 

Postgraduate Institute for Medicine (PIM) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME activities. All relevant conflicts of interest that are identified are thoroughly vetted by PIM for fair balance, scientific objectivity of studies mentioned in this activity, and patient care recommendations. PIM is committed to providing its learners with high-quality CME activities and related materials that promote improvements or quality in health care and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or
relationships to products or devices they or their spouse/life partner have with commercial interests related to the content
of this CME activity.
Keith C. Meyer, MD, MS, FACP, FCCP
Receipt of Intellectual Property Rights/Patent Holder: #7,579,156 (25 Aug 2009): Fluorescent Phospholipase Assay, Phospholipase A2 Inhibitor and Stimulator, and the Use Thereof – University of Wisconsin
Consulting Fees: Bayer, Inc, Pharmaxis, Inc.
Contracted Research: Actelion, Gilead Sciences, Inspire Pharmaceuticals, InterMune, Pharmaxis, Inc, PPD Development,
XDX Largo

Christopher M. Oermann, MD
Contracted Research: Gilead Sciences, Inspire Pharmaceuticals

Felix Ratjen, MD, PhD, FRCP(C)
Fees for Non-CME Services: Inspire Pharmaceuticals, Novartis

Gregory Tino, MD
Stock: Gilead Sciences, Pharmaxis, Inc.

The following PIM planners and managers, Jan Hixon, RN, BSN, MA, Trace Hutchison, PharmD, Julia Kimball, RN, BSSN, Samantha Mattiucci, PharmD, and Jan Schultz, RN, MSN, CCMEP, hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.

The following HealthmattersCME planners and managers, Joanne Cullina, MSN, APN, and James Murphy, reported that they do not have any financial relationships or relationships to products or devices with any commercial interests related to the content of this CME activity.

There are no fees for participating and receiving CME credit for this activity. During the period April 5, 2010 through April 5, 2011, participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; 3) complete the posttest by recording the best answer to each question in the answer key on the evaluation form; 4) complete the evaluation form; and 5) mail or fax the evaluation form with answer key to Postgraduate Institute for Medicine.

A statement of credit will be issued only upon receipt of a completed activity evaluation form and a completed posttest with a score of 70% or better. Your statement of credit will be mailed to you within 3 weeks.
 

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Postgraduate Institute for Medicine (PIM), HealthmattersCME, and Gilead Sciences do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of PIM, HealthmattersCME, and Gilead Sciences. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
 

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
 

This activity is jointly sponsored by Postgraduate Institute for
Medicine and HealthmattersCME.
 

This activity is supported by an independent educational grant
from Gilead Sciences Medical Affairs.



**Once the "Launch Activity" button is clicked, it may take a minute or more to download.